Celldex Therapeutics, Inc. — Director's Dealing 2009

Dec 24, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2009-12-23

Reporting Person: LIPTON KAREN SHOOS (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-12-23	Common Stock	A	2000	—	Acquired	2000	Direct

Footnotes

F1: On December 23, 2009, the Company awarded 2,000 shares of Company common stock as an annual equity grant (in the form of restricted stock awards under the Plan, subject to time-based forfeiture restrictions.)